These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of generic competition on the price of brand-name drugs. Lexchin J. Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552 [Abstract] [Full Text] [Related]
5. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Liu SZ, Romeis JC. Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666 [Abstract] [Full Text] [Related]
7. Fixed budgets as a cost containment measure for pharmaceuticals. Granlund D, Rudholm N, Wikström M. Eur J Health Econ; 2006 Mar; 7(1):37-45. PubMed ID: 16435117 [Abstract] [Full Text] [Related]
12. Out-of-pocket costs to users: medicine options for hypertension. Arredondo A. Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138 [No Abstract] [Full Text] [Related]
14. Prescription drugs and medical costs: four opportunities for health plans and physicians to make a difference. Greczyn RJ. N C Med J; 2003 May; 64(6):285-6. PubMed ID: 14983619 [No Abstract] [Full Text] [Related]
18. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Mott DA, Cline RR. Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180 [Abstract] [Full Text] [Related]